Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

AI Catrina; D Makrygiannakis; E af Klint; SB Catrina; S Ernestam; L Klareskog; AK Ulfgren

首页> 外文期刊>Arthritis Research >Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

【24h】

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

机译：类风湿关节炎滑膜中抗肿瘤坏死因子和糖皮质激素治疗对RANKL /骨保护素系统调节的不同模式

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Arthritis Research》 |2005年第1期|共页
作者
AI Catrina; D Makrygiannakis; E af Klint; SB Catrina; S Ernestam; L Klareskog; AK Ulfgren;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium [J] . AI Catrina, S Ernestam, E af Klint, Arthritis Research . 2004,第Suppla1期

机译：抗肿瘤坏死因子疗法可调节类风湿关节炎滑膜中的OPG / OPGL系统
2. Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: A cohort study in the dutch rheumatoid arthritis monitoring (DREAM) registry [J] . vanDartelS.A.A., FransenJ., KievitW., Rheumatology . 2013,第6期

机译：抗肿瘤坏死因子治疗的类风湿关节炎患者5年严重感染风险的预测指标：荷兰类风湿关节炎监测（DREAM）注册表中的一项队列研究
3. Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications [J] . Bitoun Samuel, Miceli-Richard Corinne, Verstuyft Celine, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第12期

机译：肿瘤坏死因子α受体超家族1A患者患者中的患者抗肿瘤坏死因子治疗相关脱髓糖症的多发性硬化相关变体
4. Anti-tumour necrosis factor therapy in clinical practice: what is advance and what is not? [C] . Falk Symposium . 2004

机译：临床实践中的抗肿瘤坏死因子治疗：什么是进步，什么不是？
5. Predictors of Infection in Rheumatoid Arthritis Patients Using Anti-Tumor Necrosis Factor Agents [D] . Liu, Tasia 2017

机译：类风湿关节炎患者使用抗肿瘤坏死因子药物的感染预测因子
6. Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium [O] . AI Catrina, D Makrygiannakis, E af Klint, 2005

机译：类风湿关节炎滑膜中抗肿瘤坏死因子和糖皮质激素治疗对RANKL /骨保护素系统调节的不同模式
7. Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry [O] . S. A. A. van Dartel, J. Fransen, W. Kievit, 2013

机译：用抗肿瘤坏死因子治疗对类风湿性关节炎患者严重感染的预测因子：荷兰类风湿性关节炎监测（梦想）登记处的队列研究

Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

著录项

相似文献

相关主题

期刊订阅